Karen Massey

COO

Equibles does not estimate personal net worth.

Get an email with a short summary when Argenx SE publishes a filing, an earnings call transcript or a press release.

About Karen Massey

Karen Massey is recorded as COO at Argenx SE (ARGX). Karen Massey has spoken on 13 earnings calls and 4 other investor events across 1 company, most recently for Argenx SE on October 22, 2026. Argenx SE is classified in the Biotechnology industry within the Healthcare sector.

Karen Massey on recent calls

“This has been another outstanding quarter for Argenix. Nearly five years into launch, we're still early in realizing VivGuard's potential across MG and CIDP.”

CEO, Third Quarter 2026 Financial Results and Business Update · October 22, 2026

“It's been an exciting couple of months for Argenix, a very busy few months just in the Argenix way. So, you know, we have laid out our vision for the company as Vision 2030.”

CEO, argenx to Present at Wells Fargo 21st Annual Healthcare Conference · September 8, 2026

“It's been an exciting couple of months for Argenix, a very busy few months just in the Argenix way. So, you know, we have laid out our vision for the company as Vision 2030.”

CEO, argenx to Present at Wells Fargo 21st Annual Healthcare Conference · September 1, 2026

“The team delivered one of our strongest quarters yet, marking our 18th consecutive quarter of growth. This momentum reflects the value Vivga continues to deliver for patients, the continued expansion of both MG and CIDP markets, and our ability to unlock new opportunities for growth.”

CEO, Half Year 2026 Financial Results and Second Quarter Business Update · July 23, 2026

“I guess do you need to see more data from 124 before making that determination of which one is new indications, which ones you know kind of follow-on or are there any external data points that you're also evaluating when in trying to make those decisions?”

COO, argenx to Present at William Blair 46th Annual Growth Stock Conference · June 3, 2026